CALIFORNIA FOCUS
FOR RELEASE: TUESDAY, OCTOBER 20, 2020 OR THEREAFTER
BY THOMAS D. ELIAS
“TWO RERUN PROPOSITIONS THAT
DESERVE LOW RATINGS”
This
fall’s California ballot contains definite head-scratchers: Two repeat
propositions that – based on their 2018 showings – probably did not deserve a
rerun nearly this soon.
Just
two years ago, voters opted by almost identical margins of 61-39 percent and 62-38
percent to reject the 2018 Propositions 8 and 10, one mandating significant
increases in staffing at dialysis centers that preserve the lives of more than
80,000 patients with end-stage kidney disease, the other allowing rent controls
everywhere in California.
It’s
not unusual for initiative sponsors to bring their ideas to the ballot
repeatedly, despite the multi-million-dollar costs of petition signature drives
and the campaign ads required later on. Only very occasionally does a rerun
succeed. The last significant one was the landmark 1978 Proposition 13 property
tax limit measure, which was an outgrowth, but not a replica, of another
initiative that failed earlier, in a 1973 special election staged by order of
then-Gov. Ronald Reagan.
Today’s
reruns are not quite as far reaching as that one, and their original versions
lost by much larger margins than the original try at limiting property taxes.
This
fall, Propositions 21 and 23 are almost identical to their losing predecessors.
Prop.
21, again sponsored by the Los Angeles-based AIDS Healthcare Foundation, is
slightly tougher than its defeated forebear. It would limit rent increases to 5
percent per year, plus the local rate of inflation in locales which now have no
rent control. Existing rent controls would continue in places like Santa
Monica, Los Angeles, Glendale, Cotati, San Francisco and a few other cities.
For
what it’s worth, those controls have not ended the housing affordability crisis
anywhere; some of the highest-priced rentals in America exist in Santa Monica
and San Francisco, both with strict controls for decades.
These
are also among the densest areas in California, scores of new apartment
buildings having risen in recent years to replace older, smaller ones. Most
city rent control laws exempt new construction, usually defined as less than 15
years old but extending back to 1978 in some cities. So it pays for developers
to buy up older buildings, evict longtime tenants and build newer units where
they can charge market rates, which have climbed steadily for many years.
A
new state law passed in 2019 aims to mitigate this somewhat by making evictions
of paid-up renters more difficult. And no one yet knows the long-term effects
of coronavirus eviction limits.
The
arguments on both sides here are the same as they were two years ago, meaning
the real question is whether the political climate has changed in California
and how far left any such changes may have swung the state.
The
Prop. 23 dialysis proposition, another big loser two years ago, is at least as
flawed as its predecessor. It essentially interferes with the medical care of
persons often too weak or debilitated to advocate for their own interests.
(Full disclosure: Columnist Elias has had a
kidney transplant since 1997. He underwent regular dialysis treatments for many
months prior to his transplant.)
Sponsored mainly by the powerful Service Employees International
Union, this measure would force the more than 550 dialysis clinics which clean
the blood of patients in all parts of California to add more staff at the same
time it forbids clinics from charging insurance companies for the work of
physician medical directors vital to maintaining quality medical care.
If
this discourages clinic visits by nephrologists and spurs some to stop making
rounds there at all, it would severely interfere with medical treatment.
The
main funding for opposition to this measure comes from two multinational
companies – the German-based Fresenius Medical Care and Denver-based DaVita Corp.
Together, these firms operate about 70 percent of California dialysis clinics.
Besides owning clinics, Fresenius is among the largest makers of dialysis
machines.
Both
Fresenius and DaVita contend, as they did in 2018, that passage of Prop. 23 would
force them to close many clinics, especially in rural areas, thus forcing
already disabled patients to travel long distances for vital treatments.
Neither
of these measures is back by popular demand. Both deserve to lose at least as
badly as they did before.
-30-
Email
Thomas Elias at tdelias@aol.com. His book, "The Burzynski Breakthrough,
The Most Promising Cancer Treatment and the Government’s Campaign to Squelch
It," is now available in a soft cover fourth edition. For more Elias
columns, visit www.californiafocus.net
No comments:
Post a Comment